Reuter James Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History
Reuter James Wealth Management, LLC
- $552 Million
- Q1 2025
A detailed history of Reuter James Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Reuter James Wealth Management, LLC holds 1,567 shares of VRTX stock, worth $680,673. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,567
Previous 1,697
7.66%
Holding current value
$680,673
Previous $683,000
11.13%
% of portfolio
0.14%
Previous 0.13%
Shares
14 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
233MCall Options Held
1.25MPut Options Held
973K-
Capital World Investors Los Angeles, CA28.5MShares$12.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.31 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.12 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $112B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...